Charles Schwab CRO Nigel Murtagh sells over $3.4m in stock By Investing.com

Nigel J. Murtagh, Chief Risk Officer at Charles Schwab Corp (), sold 32,947 shares of the company’s common stock on July 27, 2026, for a total value of $3,426,836. These sales were preceded by the exercise of stock options.

The sales comprised two distinct transactions. Mr. Murtagh sold 21,947 shares at a weighted average price of $104.00 per share, generating $2,282,488. These shares were executed in multiple trades with prices ranging from $103.95 to $104.075. Additionally, he sold 11,000 shares at a weighted average price of $104.0317 per share, totaling $1,144,348. These transactions were conducted under a Rule 10b5-1 trading plan, which was adopted on November 25, 2025. The sale came as Charles Schwab trades near its 52-week high of $107.50, with the stock showing strong momentum. According to InvestingPro analysis, the stock remains undervalued with a Fair Value of $123, suggesting potential upside despite recent gains.

Prior to these sales, Mr. Murtagh acquired 32,947 shares of common stock by exercising nonqualified stock options at a price of $46.81 per share, amounting to a total value of $1,542,249. These options were granted under the company’s 2013 Stock Incentive Plan and vested in four annual installments beginning on the first anniversary of the grant date.

Following these transactions, Nigel J. Murtagh directly holds 57,972.4846 shares of Charles Schwab Corp common stock and indirectly holds 2,621 shares through an Employee Stock Purchase Plan (ESPP). He also directly owns 15,675 nonqualified stock options.

In other recent news, Charles Schwab reported robust second-quarter 2026 earnings, surpassing Wall Street expectations. The company achieved adjusted earnings of $1.62 per share on revenue of $7.1 billion, exceeding analyst estimates of $1.54 per share and $6.85 billion in revenue. This performance marks a 21% increase in revenue and a 42% rise in earnings compared to the previous year. Following these results, UBS raised its price target for Charles Schwab to $128, maintaining a Buy rating, while Wolfe Research increased its target to $127, citing positive results and enhanced guidance for fiscal 2026. Citizens also reiterated its Market Outperform rating, highlighting the strong earnings beat. Additionally, Piper Sandler raised its price target to $118, noting the positive quarter driven by a favorable retail trading environment and balance sheet growth. These developments reflect Charles Schwab’s continued success in gaining clients and benefiting from increased lending and trading activities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.